LOS ANGELES -- (Business Wire)
Glancy
Binkow & Goldberg LLP reminds investors in Omnicell,
Inc. (“Omnicell” or the “Company”) (NASDAQ: OMCL) who purchased the
Company’s between May 2, 2014 and March 2, 2015, inclusive (the “Class
Period”) of the May 18, 2015 deadline, to file a motion to be appointed
as lead plaintiff in the shareholder lawsuit.
Investors who purchased Omnicell shares during the Class Period are
encouraged to contact Casey Sadler of Glancy Binkow & Goldberg LLP, 1925
Century Park East, Suite 2100, Los Angeles, California 90067, at (310)
201-9150, by e-mail to shareholders@glancylaw.com,
or visit our website at http://www.glancylaw.com.
If you inquire by email, please include your mailing address, telephone
number and number of shares purchased. If you are a member of the Class
described above, you may move the Court no later than May 18, 2015 to
serve as lead plaintiff, if you meet certain legal requirements. To be a
member of the Class, you need not take any action at this time; you may
retain counsel of your choice or take no action and remain an absent
member of the Class.
Omnicell provides automation and business information solutions designed
to enable hospitals and long-term healthcare facilities to acquire,
manage, dispense and administer medications and medical-surgical
supplies. The Complaint alleges that defendants made false and
misleading statements or failed to disclose material adverse facts,
including the existence of a “side letter” arrangement with a Company
customer for certain discounts and Company products that were to be
provided at no cost, but which were not reflected in the final invoices
paid by the customer; and, that the Company lacked adequate internal
controls over financial reporting. On March 2, 2015, the Company
announced the need to delay the filing of its annual report, because of
the alleged “side letter” arrangement described above. Following
disclosure of the above news, Omnicell shares fell $2.14 per share, or
more than 6%, on March 3, 2015.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
Contacts:
Glancy Binkow & Goldberg LLP, Los Angeles
Casey Sadler,
310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com
Source: Glancy Binkow & Goldberg LLP
© 2024 Canjex Publishing Ltd. All rights reserved.